Arrowhead Pharmaceuticals... (ARWR)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
19.90
-1.06 (-5.06%)
At close: Feb 21, 2025, 3:59 PM
19.90
0.00%
After-hours: Feb 21, 2025, 04:00 PM EST
Arrowhead Pharmaceuticals Revenue
Arrowhead Pharmaceuticals reported an annual revenue of $3.55M, reflecting a -98.52% growth. For the quarter ending December 31, 2024, Arrowhead Pharmaceuticals generated $2.5M in revenue.
Revenue (ttm)
$3.55M
Revenue Growth
-98.52%
Price / Sales Ratio
653.4
Revenue / Employee
$5.83K
Employees
609
Market Cap
2.51B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|---|---|
2024-09-30 | 3.55M | -98.52% |
2023-09-30 | 240.74M | -1.03% |
2022-09-30 | 243.23M | +75.89% |
2021-09-30 | 138.29M | +57.16% |
2020-09-30 | 87.99M | n/a |